Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response

• Thomas H. P. M. Habets,

  Affiliations Division of Hematology, Department of Internal Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands, Tissue Typing Laboratory, Department of Transplantation Immunology, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Tammy Oth,

  Affiliation Division of Hematology, Department of Internal Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Ans W. Houben,

  Affiliations Division of Hematology, Department of Internal Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands, Division of Nuclear Medicine, Department of Internal Medicine, School of NUTRIM, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Mirelle J. A. J. Huijskens,

  Affiliation Division of Hematology, Department of Internal Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Birgit L. M. G. Senden-Gijsbers,

  Affiliation Division of Hematology, Department of Internal Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Melanie C. A. Schnijderberg,

  Affiliation Division of Hematology, Department of Internal Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Boudewijn Brans,

  Affiliation Division of Nuclear Medicine, Department of Internal Medicine, School of NUTRIM, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Ludwig J. Dubois,

  Affiliation MaastRO Laboratory, Department of Radiation Oncology, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Philippe Lambin,

  Affiliation MaastRO Laboratory, Department of Radiation Oncology, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Marijke De Saint-Hubert,

  Affiliation Division of Nuclear Medicine, Department of Internal Medicine, School of NUTRIM, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Wilfred T. V. Germeraad,

  Affiliations Division of Hematology, Department of Internal Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands, CiMaas BV, Maastricht, The Netherlands

  ⨯
• Marcel G. J. Tilanus,

  Affiliation Tissue Typing Laboratory, Department of Transplantation Immunology, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Felix M. Mottaghy,

  Affiliation Division of Nuclear Medicine, Department of Internal Medicine, School of NUTRIM, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯
• Gerard M. J. Bos ,

  Contributed equally to this work with: Gerard M. J. Bos, Joris Vanderlocht

  Affiliations Division of Hematology, Department of Internal Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands, CiMaas BV, Maastricht, The Netherlands

  ⨯
• Joris Vanderlocht

  Contributed equally to this work with: Gerard M. J. Bos, Joris Vanderlocht

  * E-mail: joris.vanderlocht@mumc.nl

  Affiliation Tissue Typing Laboratory, Department of Transplantation Immunology, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center +, Maastricht, The Netherlands

  ⨯